Cited by 146Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

Efficacy of Catheter Ablation for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Evidence From Randomized and Nonrandomized Controlled Trials

Wynn, Gareth J., Das, Moloy, Bonnett, Laura J., Panikker, Sandeep, Wong, Tom, Gupta, Dhiraj·2014·Circulation Arrhythmia and Electrophysiology

Abstract

BACKGROUND: Catheter ablation (CA) is commonly performed for persistent atrial fibrillation, but few high-quality randomized controlled trials (RCTs) exist, leading to funding restrictions being proposed in several countries. We performed a random-effects meta-analysis of RCTs and non-RCTs to assess the efficacy of CA for persistent atrial fibrillation. METHODS AND RESULTS: We systematically searched PubMed, EMBASE, CENTRAL, OpenGrey, and clinicaltrials.gov for RCTs and non-RCTs reporting clinical outcomes after CA for persistent atrial fibrillation. Forty-six eligible studies were identified containing 3819 patients. After a single procedure, CA significantly reduced the risk of recurrent atrial fibrillation compared with medical therapy (odds ratio [OR], 0.32; 95% confidence interval [CI], 0.20-0.53; P<0.001). Outcomes were better if the pulmonary veins were encircled (OR, 0.26; 95% CI, 0.09-0.74; P=0.01), and electrical isolation reduced AF recurrence compared with purely anatomic encirclement (OR, 0.33; 95% CI, 0.13-0.86; P=0.02). Linear ablation within the left atrium (OR, 0.22; 95% CI, 0.10-0.49; P<0.001), but not complex fractionated atrial electrogram ablation (OR, 0.64; 95% CI, 0.35-1.18; P=0.15), significantly reduced AF recurrence. Results were not improved by performing more extensive linear lesion sets (OR, 0.77; 95% CI, 0.41-1.43; P=0.40) or from biatrial ablation (OR, 0.62; 95% CI, 0.31-1.24; P=0.17). Where data were available, the relative benefits seen held true both after a single or multiple procedure(s). Sensitivity analyses showed that inclusion of non-RCTs increased statistical power without biasing the calculated effect sizes. CONCLUSIONS: For patients with persistent atrial fibrillation, CA achieves significantly greater freedom from recurrent atrial fibrillation compared with medical therapy. The most efficacious strategy is likely to combine isolation of the pulmonary veins with limited linear ablation within the left atrium.

Integrity signals

Registry

Crossref · 10.1161/circep.114.001759

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wynn, G. J., Das, M., Bonnett, L. J., Panikker, S., Wong, T., & Gupta, D.
Affiliations
University of Liverpool (GB)
Venue
Circulation Arrhythmia and Electrophysiology
Published
2014-10
Volume
7
Issue
5
Pages
841-852
ISSN
  • 1941-3084 (ISSN-L)
  • 1941-3149
OpenAlex
W2150808288
Cited by
146
References
69
Citations by year
2026: 4 · 2025: 3 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 21 · 2018: 12 · 2017: 23 · 2016: 29 · 2015: 17 · 2014: 1
FWCI
16.00
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation Arrhythmia and Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Boston Scientific Corporation
  • Biosense Webster
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
catheter ablation, persistent atrial fibrillation, atrial fibrillation recurrence, pulmonary vein isolation, linear ablation, biatrial ablation, treatment comparison, left atrium, treatment efficacy
MeSH terms
Anti-Arrhythmia Agents, Atrial Fibrillation, Heart Atria, Humans, Pulmonary Veins, Recurrence, Risk Factors, Time Factors, Odds Ratio, Randomized Controlled Trials as Topic, Treatment Outcome, Catheter Ablation, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review